Lluı́s Pagès

625 total citations
17 papers, 496 citations indexed

About

Lluı́s Pagès is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Lluı́s Pagès has authored 17 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 2 papers in Physiology. Recurrent topics in Lluı́s Pagès's work include Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Phosphodiesterase function and regulation (4 papers) and Catalytic Alkyne Reactions (3 papers). Lluı́s Pagès is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Phosphodiesterase function and regulation (4 papers) and Catalytic Alkyne Reactions (3 papers). Lluı́s Pagès collaborates with scholars based in Spain, Jordan and United States. Lluı́s Pagès's co-authors include Amadeu Gavaldà, Martin D. Lehner, Josep M. Moretó, Francisco Camps, Marta Pérez-Garay, Beatriz Arteta, Rosa Peracaula, Rafael de Llorens, Fernando Vidal‐Vanaclocha and Carme de Bolós and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Lluı́s Pagès

17 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lluı́s Pagès Spain 13 288 253 109 56 49 17 496
Matthew C. Lucas United States 16 159 0.6× 220 0.9× 88 0.8× 33 0.6× 28 0.6× 32 530
Brian Dupré United States 10 206 0.7× 198 0.8× 84 0.8× 30 0.5× 48 1.0× 14 443
Shin Iimura Japan 15 262 0.9× 302 1.2× 26 0.2× 47 0.8× 95 1.9× 26 540
Mark Charles United Kingdom 8 205 0.7× 247 1.0× 28 0.3× 22 0.4× 43 0.9× 9 498
Craig Swearingen United States 15 182 0.6× 82 0.3× 48 0.4× 56 1.0× 97 2.0× 21 423
Kiyoshi Inoguchi Japan 12 137 0.5× 207 0.8× 56 0.5× 16 0.3× 36 0.7× 18 399
Qiuming Pan China 7 268 0.9× 90 0.4× 96 0.9× 54 1.0× 55 1.1× 10 402
Marie‐Paule Hildebrand France 14 336 1.2× 271 1.1× 43 0.4× 51 0.9× 120 2.4× 17 630
Stephen C. Yabut United States 10 210 0.7× 205 0.8× 46 0.4× 20 0.4× 37 0.8× 14 417
Stéphane Peluso Switzerland 8 556 1.9× 142 0.6× 44 0.4× 25 0.4× 83 1.7× 11 723

Countries citing papers authored by Lluı́s Pagès

Since Specialization
Citations

This map shows the geographic impact of Lluı́s Pagès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluı́s Pagès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluı́s Pagès more than expected).

Fields of papers citing papers by Lluı́s Pagès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluı́s Pagès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluı́s Pagès. The network helps show where Lluı́s Pagès may publish in the future.

Co-authorship network of co-authors of Lluı́s Pagès

This figure shows the co-authorship network connecting the top 25 collaborators of Lluı́s Pagès. A scholar is included among the top collaborators of Lluı́s Pagès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluı́s Pagès. Lluı́s Pagès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pagès, Lluı́s, Sònia Espinosa, Mónica Maldonado, et al.. (2018). Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases. Journal of Medicinal Chemistry. 61(21). 9551–9567. 25 indexed citations
2.
Pérez-Garay, Marta, Beatriz Arteta, Esther Llop, et al.. (2013). α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. The International Journal of Biochemistry & Cell Biology. 45(8). 1748–1757. 74 indexed citations
3.
Gavaldà, Amadeu, Elena Calama, J.L. Montero, et al.. (2011). Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors. European Journal of Medicinal Chemistry. 46(10). 4946–4956. 14 indexed citations
4.
Pérez-Garay, Marta, Beatriz Arteta, Lluı́s Pagès, et al.. (2010). α2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo. PLoS ONE. 5(9). e12524–e12524. 73 indexed citations
5.
Gavaldà, Amadeu, Montserrat Miralpeix, Dolors Vilella, et al.. (2010). Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors. Journal of Medicinal Chemistry. 53(19). 6912–6922. 28 indexed citations
6.
Pagès, Lluı́s, Amadeu Gavaldà, & Martin D. Lehner. (2009). PDE4 inhibitors: a review of current developments (2005 – 2009). Expert Opinion on Therapeutic Patents. 19(11). 1501–1519. 81 indexed citations
7.
Bonjoch, Josep, et al.. (2009). Synthesis and structure–activity relationships of γ-carboline derivatives as potent and selective cysLT1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(15). 4299–4302. 16 indexed citations
8.
Fonquerna, Sı́lvia, M. Miralpeix, Lluı́s Pagès, et al.. (2005). Synthesis and structure–activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 1165–1167. 12 indexed citations
9.
Fonquerna, Sı́lvia, M. Miralpeix, Lluı́s Pagès, et al.. (2004). Synthesis and Structure−Activity Relationships of Novel Histamine H1 Antagonists:  Indolylpiperidinyl Benzoic Acid Derivatives. Journal of Medicinal Chemistry. 47(25). 6326–6337. 21 indexed citations
10.
Vilaseca, Fabiola, et al.. (1998). Preference for β-H elimination in the termination of the Ni-promoted carbonylative cycloaddition of 2-haloethylidene-cycloalkanes and alkynes. Journal of Organometallic Chemistry. 551(1-2). 107–115. 5 indexed citations
11.
Crespo, M., Lluı́s Pagès, Armando Vega, et al.. (1998). Design, Synthesis, and Biological Activities of New Thieno[3,2-d]pyrimidines as Selective Type 4 Phosphodiesterase Inhibitors. Journal of Medicinal Chemistry. 41(21). 4021–4035. 36 indexed citations
13.
Diez, Anna, Isabel López, Mario Rubiralta, et al.. (1995). Synthetic applications of 2-aryl-4-piperidones. X Synthesis of 3-aminopiperidines, potential substance P antagonists. Tetrahedron. 51(17). 5143–5156. 13 indexed citations
14.
Pagès, Lluı́s, Amadeu Llebaria, Francisco Camps, et al.. (1992). Ring-fused and spiro cyclopentenones by Ni(CO)4-promoted intermolecular carbonylative cycloaddition of acetylenes with 3-halo- and 1-(halomethyl)cycloalkenes. Journal of the American Chemical Society. 114(26). 10449–10461. 49 indexed citations
15.
Camps, Francisco, Amadeu Llebaria, Josep M. Moretó, & Lluı́s Pagès. (1992). Fused bicyclic systems through a ni-mediated intermolecular cyclopentenone annulation. Tetrahedron Letters. 33(1). 109–112. 12 indexed citations
16.
Camps, Francisco, Josep M. Moretó, & Lluı́s Pagès. (1992). Influence of functional substitution of allyl halides on their ni(co)4 promoted carbonylative cycloaddition with acetylenes. Tetrahedron. 48(15). 3147–3162. 20 indexed citations
17.
Camps, Francisco, Amadeu Llebaria, Josep M. Moretó, & Lluı́s Pagès. (1992). New practical synthesis of spirocyclopentenones. Tetrahedron Letters. 33(1). 113–114. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026